ASTA (246720) | AccidentalOrder

KOSDAQ · 6,070 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

99.4B

Rev (2022)

3.3B

Op Inc (2022)

-2.8B

Net Inc (2022)

-2.8B

PBR

10.78

52W

5K~9K

ASTA operates in the Pharmaceuticals sector.

Legal name: ASTA Co., Ltd.

In fiscal year 2022, ASTA (246720) reported revenue of 3.3 billion KRW, up 30.5% from 2.6 billion KRW a year earlier.

Operating profit was -2.8 billion KRW and net income was -2.8 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 99.4 billion KRW, with a P/B of 10.78.

These figures can be verified in the DART filing (receipt no. 20260331001631).

Year	Rev	Op Inc	Net Inc
2022	3.3B	-2.8B	-2.8B
2021	2.6B	-3.5B	-3.5B
2020	1.3B	-6.1B	-11.1B
2019	1.3B	-6.2B	-15.0B

4 applicable out of 8 items

Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)

Semi-Annual Report (2026.06)

Checks

4 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 2 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Disclaimer of opinion. [source]

Convertible Bonds: Convertible bonds outstanding with 0.03% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 6 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)
2026-08-14	Semi-Annual Report (2026.06)